查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1629216

血液動力學流量改變設備市場，按類型、應用、最終用途、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Hemodynamic Flow Alteration Devices Market, By Type, By Application, By End-Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 395 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023 年，血流動力學改變裝置市場規模為 8.0567 億美元，2024 年至 2032 年複合年成長率為 8.5%。

血流動力學流量改變裝置市場-市場動態

包括心臟衰竭和缺血性心臟病在內的心血管疾病盛行率不斷上升，推動市場需求

心血管疾病（CVD），特別是心臟衰竭和缺血性心臟病的盛行率不斷增加，推動了對血流動力學改變裝置的需求不斷成長。隨著人口老化，心臟衰竭和缺血性心臟病的發生率持續上升。據世界衛生組織 (WHO) 稱，CVD 是全球主要死亡原因，約佔全球死亡總數的 32%。心臟病負擔的增加迫切需要支持心臟功能並提高患者存活率的醫療設備。心室輔助裝置 (VAD)、主動脈內球囊反搏幫浦 (IABP) 和體外膜氧合 (ECMO) 等設備對於在危急情況下穩定患者並增強循環至關重要。這些設備可防止器官衰竭、提供氧合併提供機械支持，為患者提供恢復或更明確治療所需的時間。此外，這些技術的進步使設備更加有效和易於使用，從而進一步提高了它們的採用率。對這些設備的需求不斷成長，是因為迫切需要解決全球日益成長的心血管負擔，尤其是心血管疾病仍然是第一大死因，每年影響數百萬人。

血流動力學流量改變設備市場 - 關鍵見解

  • 根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 8.5% 左右的複合年成長率成長
  • 根據類型細分，預計慢性完全封堵器將在 2023 年顯示最大的市場佔有率
  • 從應用細分來看，心臟器械是2023年的主導類型
  • 按地區分類，北美是 2023 年的主要收入來源

血流動力學流量改變裝置市場區隔分析：

全球血流動力學改變設備市場根據類型、應用、最終用途和地區進行細分。

市場依類型分為兩類：栓塞防護裝置和慢性完全閉塞裝置。慢性完全閉塞裝置在市場上佔據主導地位，因為它在治療無法透過標準血管成形術解決的複雜冠狀動脈阻塞患者方面發揮關鍵作用。冠狀動脈疾病的盛行率不斷上升，加上對微創手術的需求不斷成長，推動了 CTO 設備的採用，該設備可顯著改善患者的治療結果，並降低併發症發生率。

市場依應用分為三類：心臟設備、腦流設備及周邊循環設備。心臟器材在市場上佔據主導地位，並且由於冠狀動脈疾病、心臟衰竭和心律不整等心血管疾病的盛行率不斷增加，需要先進的醫療干預措施來改善患者的預後，因此在預測期內可能會保持其主導地位。

血流動力學改變裝置市場 - 地理洞察

在醫療保健需求不斷成長和技術進步的推動下，不同地區的血流動力學流量改變裝置市場正在經歷顯著成長。北美，特別是美國，由於醫療保健支出高、人口老化程度高以及先進醫療技術的採用增多，在市場上佔據主導地位。該地區強大的醫療基礎設施支援心室輔助裝置 (VAD)、主動脈內球囊反搏泵 (IABP) 和體外膜氧合 (ECMO) 系統等設備的廣泛使用。歐洲也呈現強勁的成長潛力，德國、英國和法國等國家投資於醫療保健創新，導致這些救生設備的採用率增加。由於心血管疾病盛行率不斷上升、醫療保健服務範圍不斷擴大以及醫療旅遊業的成長，亞太地區預計將在預測期內實現最高的成長率。日本、中國和印度等國家正在以越來越快的速度採用這些設備，政府措施和改善醫療基礎設施促進了市場的擴張。人們對心臟病的認知不斷提高以及該領域的技術進步可能會繼續推動全球血流動力學改變裝置的採用。

血流動力學流量改變裝置市場-競爭格局：

血液動力學流量改變裝置市場的競爭格局的特點是存在幾個專注於創新、策略合作夥伴關係和地理擴張以維持其市場地位的關鍵參與者。公司擴大投資於研發，以提高其設備的效率和有效性，特別強調透過侵入性更小、更方便用戶使用的解決方案來改善患者的治療結果。除了產品創新之外，合併、收購和合作也是擴大產品組合和進入新市場的常見策略。市場上還看到，來自提供穿戴式裝置和遠端監控解決方案等先進技術的公司的競爭日益激烈，這些技術由於其便利性以及與數位健康平台的整合而受到關注。此外，醫療保健提供者和機構正在成為採用這些設備的關鍵決策者，隨著公司尋求展示其產品的臨床效益、成本效益和長期優勢，從而推動競爭。隨著全球對血流動力學支援設備的需求持續成長，競爭動態也將發生變化，各公司將專注於提供解決急性和慢性心血管疾病的綜合解決方案。

最新進展：

  • 2022 年 2 月，飛利浦透過整合脈衝波多普勒增強了 Lumify 手持式超音波系統，使醫療保健專業人員能夠即時評估血流動力學和血流，從而提高各個醫療專業的診斷能力。脈衝波多普勒的加入，與B-lines 軟體等其他先進功能相結合，擴展了Lumify 的實用性，能夠更快、更準確地評估心臟、肺和血管狀況，特別是在緊急情況等照護端環境中和產科護理。
  • 2024 年 6 月，Elixir Medical 的 DynamX Bioadaptor 系統被授予 FDA 突破性設備稱號，從而可以更有效地進行監管審查。該系統旨在改善缺血性心臟病患者的冠狀動脈管腔直徑、恢復血流動力學調節並減少斑塊進展，如最近的試驗結果所示，與目前的治療方案相比，具有顯著的優勢。
  • 2022年5月，喬治亞理工學院的研究人員開發了一種無線植入式血管監測系統，由智慧支架和能夠即時血流動力學監測的印刷軟式感測器組成。這種創新設備無需電池或傳統電路即可提供動脈壓、脈搏和血流的連續資料，旨在改善高血壓和動脈粥樣硬化等血管疾病的診斷和治療，同時有可能取代昂貴的侵入性成像技術。

目錄

第 1 章：血流動力學流量改變裝置市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按類型分類的血流動力學流量改變設備市場片段
    • 血流動力學流量改變設備市場片段（依應用）
    • 依最終用途分類的血流動力學流量改變裝置市場片段
    • 按國家/地區分類的血流動力學流量改變設備市場片段
    • 按地區分類的血流動力學改變裝置市場片段
  • 競爭洞察

第 3 章：血流動力學流量改變裝置主要市場趨勢

  • 血流動力學流量改變設備市場促進因素
    • 市場促進因素的影響分析
  • 血流動力學改變裝置市場限制
    • 市場限制影響分析
  • 血流動力學改變裝置的市場機會
  • 血流動力學改變裝置市場未來趨勢

第 4 章：血液動力學流量改變裝置產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：血流動力學流量改變設備市場：地緣政治緊張局勢升級的影響

  • COVID-19 大流行的影響
  • 俄羅斯-烏克蘭戰爭的影響
  • 中東衝突的影響

第 6 章：血流動力學流量改變裝置市場格局

  • 2023 年血流動力學改變裝置市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：血流動力學流量改變設備市場 - 按類型

  • 概述
    • 按類型分類的細分市場佔有率分析
    • 栓塞防護裝置
    • 慢性全閉塞裝置

第 8 章：血流動力學流量改變設備市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 心臟裝置
    • 腦流設備
    • 末梢循環裝置

第 9 章：血流動力學流量改變設備市場 - 依最終用途

  • 概述
    • 按最終用途分類的細分市場佔有率分析
    • 門診手術中心
    • 醫院和診所

第 10 章：血流動力學流量改變設備市場 - 依地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美地區血流動力學改變裝置的主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按類型）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按最終用途）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲血流動力學改變裝置的主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按類型）
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模和預測（按最終用途）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區血流動力學改變裝置主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按類型）
    • 亞太地區市場規模與預測（按應用）
    • 亞太地區市場規模和預測（按最終用途）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲血流動力學改變裝置的主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按類型）
    • 拉丁美洲市場規模與預測（按應用）
    • 拉丁美洲市場規模和預測（按最終用途）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲血流動力學改變裝置的主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按類型）
    • 中東和非洲市場規模及預測（按應用）
    • 中東和非洲市場規模和預測（按最終用途）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 血液動力學流量改變設備產業

  • 競爭儀表板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • Abiomed, Inc.
    • Medtronic, Inc.
    • Teleflex Incorporated
    • Edwards Lifesciences Corporation
    • Getinge Group
    • Fresenius Medical Care AG & Co. KGaA
    • LivaNova PLC
    • CardiacAssist, Inc.
    • Terumo Corporation
    • BiVACOR, Inc.
    • SynCardia Systems, LLC
    • Johnson & Johnson
    • Boston Scientific Corporation
    • Philips Healthcare
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4552

REPORT HIGHLIGHT

Hemodynamic Flow Alteration Devices Market size was valued at USD 805.67 Million in 2023, expanding at a CAGR of 8.5% from 2024 to 2032.

Hemodynamic flow alteration devices are medical devices designed to modify or support blood circulation in patients with compromised hemodynamic function. These devices include intra-aortic balloon pumps (IABPs), ventricular assist devices (VADs), extracorporeal membrane oxygenation (ECMO), and various vascular grafts and stents. They are primarily used in patients with heart failure, shock, or those undergoing complex surgeries where maintaining optimal blood flow is critical. The need for these devices arises from the increasing prevalence of cardiovascular diseases, which require advanced interventions to sustain life, improve circulation, and support organs until they recover or until more definitive treatment is performed. The importance of hemodynamic flow alteration devices is underscored by their ability to provide temporary circulatory support, thus preventing organ failure and improving survival rates. Additionally, these devices are essential in critical care settings, where they help stabilize patients, provide oxygenation, and reduce the strain on the heart, allowing time for healing or recovery

Hemodynamic Flow Alteration Devices Market- Market Dynamics

Increasing prevalence of cardiovascular diseases, including heart failure and ischemic heart conditions to propel market demand

The increasing prevalence of cardiovascular diseases (CVD), particularly heart failure and ischemic heart conditions, is driving the growing demand for hemodynamic flow alteration devices. As populations age, the incidence of heart failure and ischemic heart disease continues to rise. According to the World Health Organization (WHO), CVDs are the leading cause of death globally, accounting for approximately 32% of all deaths worldwide. This increasing burden of heart disease creates an urgent need for medical devices that support heart function and improve patient survival. Devices like ventricular assist devices (VADs), intra-aortic balloon pumps (IABPs), and extracorporeal membrane oxygenation (ECMO) are crucial in stabilizing patients and enhancing circulation in critical situations. These devices prevent organ failure, provide oxygenation, and offer mechanical support, giving patients the time they need for recovery or more definitive treatment. Furthermore, advancements in these technologies are making devices more effective and accessible, further increasing their adoption. The rising demand for these devices is driven by the urgent need to address the growing global cardiovascular burden, highlighted by the fact that CVD remain the number one cause of death, impacting millions of individuals annually.

Hemodynamic Flow Alteration Devices Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.5% over the forecast period (2024-2032)
  • Based on Type segmentation, Chronic Total Occlusion Device was predicted to show maximum market share in the year 2023
  • Based on Application segmentation, Cardiac Devices was the leading type in 2023
  • Based on region, North America was the leading revenue generator in 2023

Hemodynamic Flow Alteration Devices Market- Segmentation Analysis:

The Global Hemodynamic Flow Alteration Devices Market is segmented based on Type, Application, End-Use and Region.

The market is divided into two categories based on type: Embolic Protection Device, and Chronic Total Occlusion Device. The Chronic Total Occlusion Device dominate the market due to its critical role in treating patients with complex coronary artery blockages that cannot be addressed through standard angioplasty. The increasing prevalence of coronary artery disease, coupled with the growing demand for minimally invasive procedures, drives the adoption of CTO devices, which offer significant improvements in patient outcomes and are associated with lower complication rates.

The market is divided into three categories based on Application: Cardiac Devices, Cerebral Flow Devices, and Peripheral Circulation Devices. Cardiac Devices dominate the market and are likely to maintain their dominance during the forecast period due to the increasing prevalence of cardiovascular diseases, such as coronary artery disease, heart failure, and arrhythmias, which require advanced medical interventions to improve patient outcomes.

Hemodynamic Flow Alteration Devices Market- Geographical Insights

The hemodynamic flow alteration devices market is experiencing significant growth across different regions, driven by rising healthcare needs and technological advancements. North America, particularly the United States, holds a dominant position in the market due to high healthcare spending, a large ageing population, and increased adoption of advanced medical technologies. The region's robust healthcare infrastructure supports the widespread use of devices such as ventricular assist devices (VADs), intra-aortic balloon pumps (IABPs), and extracorporeal membrane oxygenation (ECMO) systems. Europe also presents strong growth potential, with countries like Germany, the UK, and France investing in healthcare innovations, leading to increased adoption of these life-saving devices. The Asia-Pacific region is expected to experience the highest growth rate during the forecast period, driven by the growing prevalence of cardiovascular diseases, expanding healthcare access, and a rise in medical tourism. Countries like Japan, China, and India are adopting these devices at a growing rate, with government initiatives and improving healthcare infrastructure contributing to the market's expansion. The rising awareness of heart diseases and technological advancements in the field are likely to continue driving the adoption of hemodynamic flow alteration devices globally.

Hemodynamic Flow Alteration Devices Market- Competitive Landscape:

The competitive landscape of the hemodynamic flow alteration devices market is characterized by the presence of several key players focusing on innovation, strategic partnerships, and geographic expansion to maintain their market position. Companies are increasingly investing in research and development to enhance the efficiency and effectiveness of their devices, with a particular emphasis on improving patient outcomes through less invasive and more user-friendly solutions. In addition to product innovation, mergers, acquisitions, and collaborations are common strategies to expand product portfolios and enter new markets. The market is also seeing increased competition from companies offering advanced technologies like wearable devices and remote monitoring solutions, which are gaining traction due to their convenience and integration with digital health platforms. Furthermore, healthcare providers and institutions are becoming key decision-makers in the adoption of these devices, driving competition as companies seek to demonstrate the clinical benefits, cost-effectiveness, and long-term advantages of their offerings. As the demand for hemodynamic support devices continues to rise globally, the competitive dynamics will evolve, with companies focusing on delivering comprehensive solutions that address both acute and chronic cardiovascular conditions.

Recent Developments:

  • In February 2022, Philips enhanced its Lumify handheld ultrasound system by incorporating Pulse Wave Doppler, allowing healthcare professionals to assess hemodynamics and blood flow in real time, improving diagnostic capabilities across various medical specialities. The addition of Pulse Wave Doppler, combined with other advanced features like B-lines software, expands the utility of Lumify, enabling faster, more accurate assessments of heart, lung, and vascular conditions, especially in point-of-care settings such as emergency and obstetric care.
  • In June 2024, Elixir Medical's DynamX Bioadaptor System was granted FDA Breakthrough Device designation, which allows for more efficient regulatory review. The system aims to improve coronary luminal diameter, restore hemodynamic modulation, and reduce plaque progression in patients with ischemic heart disease, demonstrating significant benefits over current treatment options, as seen in recent trial results.
  • In May 2022, Georgia Tech researchers developed a wireless, implantable vascular monitoring system, which consists of a smart stent and printed soft sensors capable of real-time hemodynamic monitoring. This innovative device provides continuous data on arterial pressure, pulse, and blood flow without the need for batteries or traditional circuits, aiming to improve the diagnosis and treatment of vascular diseases, such as hypertension and atherosclerosis, while potentially replacing costly and invasive imaging techniques.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HEMODYNAMIC FLOW ALTERATION DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abiomed, Inc.
  • Medtronic, Inc.
  • Teleflex Incorporated
  • Edwards Lifesciences Corporation
  • Getinge Group
  • Fresenius Medical Care AG & Co. KGaA
  • LivaNova PLC
  • CardiacAssist, Inc.
  • Terumo Corporation
  • BiVACOR, Inc.
  • SynCardia Systems, LLC
  • Johnson & Johnson
  • Boston Scientific Corporation
  • Philips Healthcare
  • Others

GLOBAL HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Embolic Protection Device
  • Chronic Total Occlusion Device
  • Others

GLOBAL HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Cardiac Devices
  • Cerebral Flow Devices
  • Peripheral Circulation Devices

GLOBAL HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY END-USE - MARKET ANALYSIS, 2019 - 2032

  • Ambulatory Surgical Centers
  • Hospitals & Clinics

GLOBAL HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Hemodynamic Flow Alteration Devices Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Hemodynamic Flow Alteration Devices Market Snippet by Type
    • 2.1.2. Hemodynamic Flow Alteration Devices Market Snippet by Application
    • 2.1.3. Hemodynamic Flow Alteration Devices Market Snippet by End-Use
    • 2.1.4. Hemodynamic Flow Alteration Devices Market Snippet by Country
    • 2.1.5. Hemodynamic Flow Alteration Devices Market Snippet by Region
  • 2.2. Competitive Insights

3. Hemodynamic Flow Alteration Devices Key Market Trends

  • 3.1. Hemodynamic Flow Alteration Devices Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Hemodynamic Flow Alteration Devices Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Hemodynamic Flow Alteration Devices Market Opportunities
  • 3.4. Hemodynamic Flow Alteration Devices Market Future Trends

4. Hemodynamic Flow Alteration Devices Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Hemodynamic Flow Alteration Devices Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Hemodynamic Flow Alteration Devices Market Landscape

  • 6.1. Hemodynamic Flow Alteration Devices Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Hemodynamic Flow Alteration Devices Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Embolic Protection Device
    • 7.1.3. Chronic Total Occlusion Device

8. Hemodynamic Flow Alteration Devices Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Cardiac Devices
    • 8.1.3. Cerebral Flow Devices
    • 8.1.4. Peripheral Circulation Devices

9. Hemodynamic Flow Alteration Devices Market - By End-Use

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-Use, 2023 & 2032 (%)
    • 9.1.2. Ambulatory Surgical Centers
    • 9.1.3. Hospitals & Clinics

10. Hemodynamic Flow Alteration Devices Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Hemodynamic Flow Alteration Devices Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Hemodynamic Flow Alteration Devices Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Hemodynamic Flow Alteration Devices Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Hemodynamic Flow Alteration Devices Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Hemodynamic Flow Alteration Devices Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Hemodynamic Flow Alteration Devices Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Abiomed, Inc.
    • 11.2.2. Medtronic, Inc.
    • 11.2.3. Teleflex Incorporated
    • 11.2.4. Edwards Lifesciences Corporation
    • 11.2.5. Getinge Group
    • 11.2.6. Fresenius Medical Care AG & Co. KGaA
    • 11.2.7. LivaNova PLC
    • 11.2.8. CardiacAssist, Inc.
    • 11.2.9. Terumo Corporation
    • 11.2.10. BiVACOR, Inc.
    • 11.2.11. SynCardia Systems, LLC
    • 11.2.12. Johnson & Johnson
    • 11.2.13. Boston Scientific Corporation
    • 11.2.14. Philips Healthcare
    • 11.2.15. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us